Autor: "Quigley, Michael" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Autorzy:: Selby MJ
Engelhardt JJ
Johnston RJ
Lu LS
Han M
Thudium K
Yao D
Quigley M
Valle J
Wang C
Chen B
Cardarelli PM
Blanset D
Korman AJ; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Nov 18; Vol. 11 (11), pp. e0167251. Date of Electronic Publication: 2016 Nov 18 (Print Publication: 2016).
Typ publikacji:: Published Erratum

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Autorzy:: Selby MJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Engelhardt JJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Johnston RJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Lu LS; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Han M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Thudium K; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Yao D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Quigley M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Valle J; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Wang C; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Chen B; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Cardarelli PM; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Blanset D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Korman AJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Sep 09; Vol. 11 (9), pp. e0161779. Date of Electronic Publication: 2016 Sep 09 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Melanoma/*drug therapy
Animals ; Antibodies, Monoclonal/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/metabolism ; Cell Line, Tumor ; Cells, Cultured ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/therapy ; Combined Modality Therapy ; Disease Models, Animal ; Female ; Humans ; Ipilimumab ; Lymphocytes/immunology ; Lymphocytes/metabolism ; Macaca fascicularis ; Melanoma/metabolism ; Melanoma/therapy ; Mice ; Mice, Inbred C57BL ; Nivolumab ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; T-Lymphocytes, Regulatory/metabolism